Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C Zobair M. Younossi, Maria Stepanova, Linda Henry, Edward Gane, Ira M. Jacobson, Eric Lawitz, David Nelson, Lynn Gerber, Fatema Nader, Sharon Hunt Clinical Gastroenterology and Hepatology Volume 12, Issue 8, Pages 1349-1359.e13 (August 2014) DOI: 10.1016/j.cgh.2013.11.032 Copyright © 2014 AGA Institute Terms and Conditions
Figure 1 PROs in FUSION: FACIT-F (A), CLDQ-HCV (B), and WPAI (C). FACIT-F scores are normalized to 0-1 range. Red circles and triangles represent the significance of the changes from the baseline for the respective scales. Clinical Gastroenterology and Hepatology 2014 12, 1349-1359.e13DOI: (10.1016/j.cgh.2013.11.032) Copyright © 2014 AGA Institute Terms and Conditions
Figure 2 PROs in NEUTRINO: FACIT-F (A), CLDQ-HCV (B), and WPAI (C). FACIT-F scores are normalized to 0-1 range. Red circles and triangles represent the significance of the changes from the baseline for the respective scales. Clinical Gastroenterology and Hepatology 2014 12, 1349-1359.e13DOI: (10.1016/j.cgh.2013.11.032) Copyright © 2014 AGA Institute Terms and Conditions
Figure 3 Changes in PROs 12 weeks after treatment. *Significant improvement (P < .05) from baseline. Clinical Gastroenterology and Hepatology 2014 12, 1349-1359.e13DOI: (10.1016/j.cgh.2013.11.032) Copyright © 2014 AGA Institute Terms and Conditions